Altered expression of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 in transformed non-lymphoid human tissues.
about
Fetal ERAP2 variation is associated with preeclampsia in African Americans in a case-control studyMHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cellsLMNA knock-down affects differentiation and progression of human neuroblastoma cellsNonclassical MHC class Ib-restricted cytotoxic T cells monitor antigen processing in the endoplasmic reticulumBalancing selection maintains a form of ERAP2 that undergoes nonsense-mediated decay and affects antigen presentation.Promoter variant of PIK3C3 is associated with autoimmunity against Ro and Sm epitopes in African-American lupus patients.Crystallization and preliminary X-ray diffraction analysis of human endoplasmic reticulum aminopeptidase 2.IRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastomaA role for naturally occurring alleles of endoplasmic reticulum aminopeptidases in tumor immunity and cancer pre-disposition.Proteases in MHC class I presentation and cross-presentationMajor histocompatibility complex class i and tumour immuno-evasion: how to fool T cells and natural killer cells at one time.Role of endoplasmic reticulum aminopeptidases in health and disease: from infection to cancer.Human cytomegalovirus microRNA miR-US4-1 inhibits CD8(+) T cell responses by targeting the aminopeptidase ERAP1Amelioration of arthritis through mobilization of peptide-specific CD8+ regulatory T cells.Comparative expression profiling for human endoplasmic reticulum-resident aminopeptidases 1 and 2 in normal kidney versus distinct renal cell carcinoma subtypesp53 increases MHC class I expression by upregulating the endoplasmic reticulum aminopeptidase ERAP1A Novel ERAP2 Haplotype Structure in a Chilean Population: Implications for ERAP2 Protein Expression and Preeclampsia Risk.Monitoring peptide processing for MHC class I molecules in the endoplasmic reticulum.Modulating antigen processing for cancer immunotherapy.Post-proteasomal and proteasome-independent generation of MHC class I ligands.Positioning of aminopeptidase inhibitors in next generation cancer therapy.Endoplasmic reticulum aminopeptidase 1 function and its pathogenic role in regulating innate and adaptive immunity in cancer and major histocompatibility complex class I-associated autoimmune diseases.HLA class I is most tightly linked to levels of tapasin compared with other antigen-processing proteins in glioblastoma.Vaccines for established cancer: overcoming the challenges posed by immune evasion.Antigen processing and immune regulation in the response to tumours.The proteasome immunosubunits, PA28 and ER-aminopeptidase 1 protect melanoma cells from efficient MART-126-35 -specific T-cell recognition.The genetic regulation of transcription in human endometrial tissue.Endoplasmic Reticulum Aminopeptidase 2, a common immunological link to adverse pregnancy outcomes and cancer clearance?Immune evasion mechanisms of human papillomavirus: An update.ERAP1 overexpression in HPV-induced malignancies: A possible novel immune evasion mechanism.Genetic susceptibility in IBD: overlap between ulcerative colitis and Crohn's disease.Antigen Processing in the Endoplasmic Reticulum Is Monitored by Semi-Invariant αβ TCRs Specific for a Conserved Peptide-Qa-1b MHC Class Ib Ligand.The role of Endoplasmic Reticulum Aminopeptidase 2 (ERAP2) in modulating immune detection of choriocarcinoma.Integrated analysis of fine-needle-aspiration cystic fluid proteome, cancer cell secretome, and public transcriptome datasets for papillary thyroid cancer biomarker discovery.Crystal Structures of ERAP2 Complexed with Inhibitors Reveal Pharmacophore Requirements for Optimizing Inhibitor Potency.How ERAP1 and ERAP2 Shape the Peptidomes of Disease-Associated MHC-I Proteins
P2860
Q21261491-19AAD59F-FBDA-449F-9408-B8BB39C578F0Q26866479-8F6F82A1-784F-4CD8-B7CD-4A0CA4573BDAQ28484053-CF126B98-AA3A-471C-9E99-2BA36D694154Q28941251-C99011AE-82C2-4A76-BAE7-15BBFECE147DQ33728652-C0D52285-E153-46F9-8344-CB89D7D0ED30Q34022033-0CB01365-9A9E-4EE6-AD38-936726C280B5Q34268366-08F528A7-C626-4A46-9826-9FE9262512ECQ34447613-B947D024-EFEC-485A-B175-E87BE70A0921Q34741321-D6A5EE89-E344-4ABA-94E5-028D88F0CCF1Q34979864-2C8614A1-DBFC-4DA2-9261-0A82588EF0A5Q35703570-5BBD3A34-7226-4BD7-A2C6-5DBDF16F4CC5Q36197201-C1D0A1FD-2EF7-40F4-A127-ABC6F32B7C9CQ36479743-BDFE60DD-B4E0-4E64-8C2A-C8181BDF8C57Q36638222-F890CD72-B53E-43D4-AD28-7176FE0088C2Q36853385-1F9E0703-B7A5-42DF-9E3B-B8C96E5387A5Q37137155-F075BFB1-9795-4FD3-A6CC-A60D19F76FF7Q37160772-61C4362F-E508-4B62-B3CB-F95D096A309CQ37598087-3E205E96-3104-4BFA-A06A-6BAD21296159Q37706907-15BB5CEE-F70E-477D-B975-F8AEAE9E7017Q37851391-288264A5-5482-4A00-B5C8-F953FCF7EC1AQ38175346-85CEAB9F-F5FB-4587-8242-DE0AA9661281Q38234401-F7FA0B11-2F16-412D-8DCC-F37C02B08C21Q38387230-55DFF67B-C795-4C16-B6F9-7F8560B237B6Q38769021-35DFB87E-78B1-4A0E-9435-F64B7E1D290CQ38818628-C17ABECE-8DFA-4E3F-B6F1-418A0902A802Q38833090-977EDDA5-07E1-4B59-BA7D-87A0A36E1C05Q38972579-0FD9D9B2-B68A-413E-B937-3256E2619CB2Q39201032-6E01777A-3080-4C3A-AAAE-496718FD927DQ40060642-48DCEE0C-53A6-4D76-8F4B-4E775BE98FCFQ40091834-E23C96E2-E3B8-4891-A092-212668105CEDQ45159389-7B94CFE3-7728-4E83-BFF5-5B43DEF88B65Q46143093-AE3BA336-323C-4107-8A3E-C5E5314765D9Q50084777-003111AA-82C1-4367-AA76-97EECBC6F288Q52649606-CB94F61B-0C40-45A2-B05C-627BAADE112AQ52697286-71039C64-33E3-44C4-8B81-03119E9CC6E4Q58693557-324849F9-82EE-4DDD-8215-99C315EF12C4
P2860
Altered expression of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 in transformed non-lymphoid human tissues.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Altered expression of endoplas ...... ed non-lymphoid human tissues.
@en
Altered expression of endoplas ...... ed non-lymphoid human tissues.
@nl
type
label
Altered expression of endoplas ...... ed non-lymphoid human tissues.
@en
Altered expression of endoplas ...... ed non-lymphoid human tissues.
@nl
prefLabel
Altered expression of endoplas ...... ed non-lymphoid human tissues.
@en
Altered expression of endoplas ...... ed non-lymphoid human tissues.
@nl
P2860
P50
P356
P1476
Altered expression of endoplas ...... ed non-lymphoid human tissues.
@en
P2093
Maria R Nicotra
Pier Giorgio Natali
P2860
P304
P356
10.1002/JCP.21454
P577
2008-09-01T00:00:00Z